{
  "title": "Third Vaccine On The Way, Fauci Hails 'Spectacular Results'",
  "description": "A third COVID-19 vaccine could receive emergency use authorization from the Food and Drug Administration this month. The vaccine made by Johnson & Johnson is 66% effective in preventing moderate to severe disease, according to a global study. <br/><br/>Combined with the two vaccines currently in circulation, the U.S. could have three vaccines that are all highly effective at preventing death or hospitalization due to COVID-19.<br/><br/>Despite that promising news, NPR's <a href=\"https://www.npr.org/people/2100631/richard-harris\">Richard Harris</a> reports on why <a href=\"https://www.npr.org/sections/health-shots/2021/02/03/963373971/a-rocky-road-on-the-way-to-herd-immunity-for-covid-19\">the journey to herd immunity still won't be easy</a>.<br/><br/>And <a href=\"https://twitter.com/raelnb\">Rae Ellen Bichelle</a> goes inside a Colorado long-term care facility that has vaccinated nearly all of its residents. They say the initial steps to a return to normalcy feel great.<br/><br/>Additional reporting in this episode on <a href=\"https://www.npr.org/transcripts/962714261\">the spread of coronavirus variants</a> from NPR's <a href=\"https://www.npr.org/people/2100208/allison-aubrey\">Allison Aubrey</a>.<br/><br/><a href=\"https://www.npr.org/sections/npr-extra/2020/09/09/909126490/where-you-can-hear-a-localized-consider-this\">In participating regions, you'll also hear a local news segment that will help you make sense of what's going on in your community.</a><br/><br/>Email us at <a href=\"mailto:considerthis@npr.org\">considerthis@npr.org</a>.",
  "pubDate": "Wed, 03 Feb 2021 17:00:55 -0500",
  "copyright": "Copyright 2020-2021 NPR - For Personal Use Only",
  "guid": "768ebe06-ca81-4d77-bb9a-e5e5139dfc5e",
  "link": "https://www.npr.org/2021/01/29/962236361/third-vaccine-on-the-way-fauci-hails-spectacular-results",
  "itunes:title": "Third Vaccine On The Way, Fauci Hails 'Spectacular Results'",
  "itunes:author": "NPR",
  "itunes:summary": "A vaccine made by Johnson & Johnson could be authorized this month, giving the U.S. three vaccines that are highly effective at preventing death from COVID-19.",
  "itunes:subtitle": "A vaccine made by Johnson & Johnson could be authorized this month, giving the U.S. three vaccines that are highly effective at preventing death from COVID-19.",
  "itunes:image": "",
  "itunes:duration": 749,
  "itunes:explicit": "no",
  "itunes:episodeType": "full",
  "content:encoded": "A third COVID-19 vaccine could receive emergency use authorization from the Food and Drug Administration this month. The vaccine made by Johnson & Johnson is 66% effective in preventing moderate to severe disease, according to a global study. <br/><br/>Combined with the two vaccines currently in circulation, the U.S. could have three vaccines that are all highly effective at preventing death or hospitalization due to COVID-19.<br/><br/>Despite that promising news, NPR's <a href=\"https://www.npr.org/people/2100631/richard-harris\">Richard Harris</a> reports on why <a href=\"https://www.npr.org/sections/health-shots/2021/02/03/963373971/a-rocky-road-on-the-way-to-herd-immunity-for-covid-19\">the journey to herd immunity still won't be easy</a>.<br/><br/>And <a href=\"https://twitter.com/raelnb\">Rae Ellen Bichelle</a> goes inside a Colorado long-term care facility that has vaccinated nearly all of its residents. They say the initial steps to a return to normalcy feel great.<br/><br/>Additional reporting in this episode on <a href=\"https://www.npr.org/transcripts/962714261\">the spread of coronavirus variants</a> from NPR's <a href=\"https://www.npr.org/people/2100208/allison-aubrey\">Allison Aubrey</a>.<br/><br/><a href=\"https://www.npr.org/sections/npr-extra/2020/09/09/909126490/where-you-can-hear-a-localized-consider-this\">In participating regions, you'll also hear a local news segment that will help you make sense of what's going on in your community.</a><br/><br/>Email us at <a href=\"mailto:considerthis@npr.org\">considerthis@npr.org</a>.",
  "enclosure": ""
}